tm logo
DEWPOINT
SEARCHED

on 26 Jul 2023

Last Applicant/ Owned by

Dewpoint Therapeutics, Inc.

451 D Street, Suite 104Boston MA 02210

US

Serial Number

2310173 filed on 15th Feb 2022

Correspondent Address

P.O. Box 2088, Station DOttawa

ONTARIO

CA

K1P5W3

DEWPOINT

Trademark usage description

diagnostic reagents for medical-scientific research use; chemical reagents for use in genetic research; reagents for research purposes of drug discove Read More

Classification Information


Class [001]
Diagnostic reagents for medical-scientific research use; chemical reagents for use in genetic research; reagents for research purposes of drug discovery and development, namely, small molecule chemicals for the treatment of disease associated with condensate biology.


Classification kind code

11

Class [005]
Pharmaceutical preparations and therapeutic agents for use in the treatment and prevention of neurodegenerative diseases, cancer, metabolic disease, auto-immune diseases, inflammation, infectious disease, prion-based diseases, cardiovascular diseases, women's health in the nature of uterine fibroids and polycystic ovary syndrome (PCOS), renal disease, pulmonary diseases, neurological disease, fibrosis, liver diseases and wound healing; diagnostic test reagents for medical purposes; reagents for use in diagnostic tests for medical purposes.


Classification kind code

11

Mark Details


Serial Number

2310173

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 22
on 26th Jul 2023
Search Recorded
Submitted for opposition 20
on 26th Jul 2023
Examiner's First Report
Submitted for opposition 223
on 26th Jul 2023
Total Provisional Refusal
Submitted for opposition 256
on 07th Feb 2023
Notification of Possible Opposition Sent
Submitted for opposition 48
on 22nd Apr 2022
Agent Changed
Submitted for opposition 257
on 07th Apr 2022
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 06th Apr 2022
Created
Submitted for opposition 31
on 06th Apr 2022
Formalized
Submitted for opposition 30
on 15th Feb 2022
Filed
Submitted for opposition 228
on 15th Feb 2022
International Registration